Featured this week: Andrew Bellizzi, MD

Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.
Borbon LC, Sherman SK, Breheny PJ, Chandrasekharan C, Menda Y, Bushnell D, Bellizzi AM, Ear PH, O'Dorisio MS, O'Dorisio TM, Dillon JS, Howe JR.Ann Surg Oncol. 2024 Nov 6. doi: 10.1245/s10434-024-16463-7. Online ahead of print.